Next Article in Journal
An Intermediate Step for the Management of Hypersensitivity to Platinum and Taxane Chemotherapy
Previous Article in Journal
Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib, Erlotinib, Afatinib, Dacomitinib, and Icotinib in the Treatment of Non-Small-Cell Lung Cancer: A Systematic Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 22
Issue 3
10.3747/co.22.2324
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Patient with Inoperable Pheochromocytoma

by
D. Brancíková
1,2,*,
Z. Mechl
1,2,
Z. Adam
1,2,
E. Jandáková
1,3,
Z. Pavlovský
1,3,
V. Válek
1,4 and
Z. Andrašina
1,4
1
Medical Faculty, Masaryk University, Brno, Czech Republic
2
Internal Hematological and Oncological Clinic, University Hospital Brno, Brno, Czech Republic
3
Institute of Pathology, University Hospital Brno, Brno, Czech Republic
4
Department of Radiology, University Hospital Brno, Brno, Czech Republic
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2015, 22(3), 216-219; https://doi.org/10.3747/co.22.2324
Submission received: 3 March 2015 / Revised: 7 April 2015 / Accepted: 6 May 2015 / Published: 1 June 2015

Abstract

Malignant pheochromocytoma is a tumour with a very low incidence that occurs sporadically or in the presence of multiple endocrine neoplasia. We present the case of a woman with a sporadic occurrence of pheochromocytoma diagnosed in the phase of multiple dissemination in the abdominal cavity and overexpressing adrenaline, noradrenaline, and dopamine. Local transarterial chemoembolization and systemic treatment with lanreotide resulted in a very good response, a decrease in the production of catecholamines for 12 months and a partial decrease for another 8 months, with stabilization of disease determined by imaging. Systemic treatment with tegafur resulted in disease stabilization lasting 50 months, after which the drug was discontinued because of adverse effects. Maintenance therapy with lanreotide continues, and no disease progression has been observed for 4 months. The treatment algorithm for such patients is multidisciplinary and must always take into account the current scope of the disease, intercurrence, and the general condition of the patient.
Keywords: pheochromocytoma; chemoembolization; lanreotide pheochromocytoma; chemoembolization; lanreotide

Share and Cite

MDPI and ACS Style

Brancíková, D.; Mechl, Z.; Adam, Z.; Jandáková, E.; Pavlovský, Z.; Válek, V.; Andrašina, Z. Patient with Inoperable Pheochromocytoma. Curr. Oncol. 2015, 22, 216-219. https://doi.org/10.3747/co.22.2324

AMA Style

Brancíková D, Mechl Z, Adam Z, Jandáková E, Pavlovský Z, Válek V, Andrašina Z. Patient with Inoperable Pheochromocytoma. Current Oncology. 2015; 22(3):216-219. https://doi.org/10.3747/co.22.2324

Chicago/Turabian Style

Brancíková, D., Z. Mechl, Z. Adam, E. Jandáková, Z. Pavlovský, V. Válek, and Z. Andrašina. 2015. "Patient with Inoperable Pheochromocytoma" Current Oncology 22, no. 3: 216-219. https://doi.org/10.3747/co.22.2324

APA Style

Brancíková, D., Mechl, Z., Adam, Z., Jandáková, E., Pavlovský, Z., Válek, V., & Andrašina, Z. (2015). Patient with Inoperable Pheochromocytoma. Current Oncology, 22(3), 216-219. https://doi.org/10.3747/co.22.2324

Article Metrics

Back to TopTop